Literature DB >> 35132594

Epidemiology and Etiopathogeny of COVID-19.

Modesto Leite Rolim Neto1, Claúdio Gleidiston Lima da Silva2, Maria do Socorro Vieira Dos Santos2, Estelita Lima Cândido2, Marcos Antônio Pereira de Lima2, Sally de França Lacerda Pinheiro2, Roberto Flávio Fontenelle Pinheiro Junior2, Claudener Souza Teixeira2, Sávio Samuel Feitosa Machado2, Luiz Fellipe Gonçalves Pinheiro2, Grecia Oliveira de Sousa2, Lívia Maria Angelo Galvão2, Karla Graziely Soares Gomes2, Karina Alves Medeiros2, Luana Araújo Diniz2, Ítalo Goncalves Pita de Oliveira2, Jéssica Rayanne Pereira Santana2, Maria Aline Barroso Rocha2, Irving Araújo Damasceno2, Thiago Lima Cordeiro2, Wendell da Silva Sales2.   

Abstract

Despite the recent announcement of the new pathogenic coronavirus to man, SARS-CoV2, a large number of publications are presented to the scientific community. An organized and systematic review of the epidemiological, etiological, and pathogenic factors of COVID-19 is presented. This is a systematic review using the databases MEDLINE, EMBASE, Web of Science, SCIELO; the descriptors coronavirus, SARS-CoV-2, etiology, epidemiology, pathophysiology, pathogenesis, COVID-19, with publications from December 2019 to January 2021, resulting in more than 800 publications and 210 selected. The data suggest that COVID-19 is associated with SAR-CoV-2 infection, with the transmission of contagion by fomites, salivary droplets, and other forms, such as vertical and fecal-oral. The bat and other vertebrates appear to be reservoirs and part of the transmission chain. The virus uses cell receptors to infect human cells, especially ACE2, like other coronaviruses. Heat shock proteins have different roles in the infection, sometimes facilitating it, sometimes participating in more severe conditions, when not serving as a therapeutic target. The available data allow us to conclude that COVID-19 is a pandemic viral disease, behaving as a challenge for public health worldwide, determining aggressive conditions with a high mortality rate in patients with risk factors, without treatment, but with the recent availability of the first vaccines.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Covid-19; Epidemiology; Etiopathogenesis

Mesh:

Substances:

Year:  2021        PMID: 35132594     DOI: 10.1007/978-3-030-85109-5_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  104 in total

Review 1.  Neurological complications of coronavirus and COVID-19.

Authors:  F J Carod-Artal
Journal:  Rev Neurol       Date:  2020-05-01       Impact factor: 0.870

2.  The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.

Authors:  Berend Jan Bosch; Ruurd van der Zee; Cornelis A M de Haan; Peter J M Rottier
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.

Authors:  T J Anderson; I T Meredith; A C Yeung; B Frei; A P Selwyn; P Ganz
Journal:  N Engl J Med       Date:  1995-02-23       Impact factor: 91.245

Review 4.  Coronavirus genome structure and replication.

Authors:  D A Brian; R S Baric
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

5.  Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.

Authors:  Abdul Mannan Baig; Areeba Khaleeq; Usman Ali; Hira Syeda
Journal:  ACS Chem Neurosci       Date:  2020-03-13       Impact factor: 4.418

Review 6.  Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.

Authors:  Rami A Al-Horani; Umesh R Desai
Journal:  Med Res Rev       Date:  2014-03-21       Impact factor: 12.944

Review 7.  Cardiovascular disease and COVID-19.

Authors:  Manish Bansal
Journal:  Diabetes Metab Syndr       Date:  2020-03-25

8.  A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.

Authors:  Bin Cao; Yeming Wang; Danning Wen; Wen Liu; Jingli Wang; Guohui Fan; Lianguo Ruan; Bin Song; Yanping Cai; Ming Wei; Xingwang Li; Jiaan Xia; Nanshan Chen; Jie Xiang; Ting Yu; Tao Bai; Xuelei Xie; Li Zhang; Caihong Li; Ye Yuan; Hua Chen; Huadong Li; Hanping Huang; Shengjing Tu; Fengyun Gong; Ying Liu; Yuan Wei; Chongya Dong; Fei Zhou; Xiaoying Gu; Jiuyang Xu; Zhibo Liu; Yi Zhang; Hui Li; Lianhan Shang; Ke Wang; Kunxia Li; Xia Zhou; Xuan Dong; Zhaohui Qu; Sixia Lu; Xujuan Hu; Shunan Ruan; Shanshan Luo; Jing Wu; Lu Peng; Fang Cheng; Lihong Pan; Jun Zou; Chunmin Jia; Juan Wang; Xia Liu; Shuzhen Wang; Xudong Wu; Qin Ge; Jing He; Haiyan Zhan; Fang Qiu; Li Guo; Chaolin Huang; Thomas Jaki; Frederick G Hayden; Peter W Horby; Dingyu Zhang; Chen Wang
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

Review 9.  Emerging coronaviruses: Genome structure, replication, and pathogenesis.

Authors:  Yu Chen; Qianyun Liu; Deyin Guo
Journal:  J Med Virol       Date:  2020-02-07       Impact factor: 2.327

10.  COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?

Authors:  Joost Boeckmans; Robim M Rodrigues; Thomas Demuyser; Denis Piérard; Tamara Vanhaecke; Vera Rogiers
Journal:  Arch Toxicol       Date:  2020-04-08       Impact factor: 6.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.